Cleanspace Holdings Ltd
ASX:CSX
Cleanspace Holdings Ltd
ASX:CSX
Price:
0.32 AUD
3.23%
Market Closed
Updated:
May 21, 2024
Cleanspace Holdings Ltd
Cost of Revenue
|
Cleanspace Holdings Ltd
Cost of Revenue Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cleanspace Holdings Ltd
ASX:CSX
|
Cost of Revenue
-AU$3.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cost of Revenue
-AU$1.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cost of Revenue
-AU$10.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
|
|
Cochlear Ltd
ASX:COH
|
Cost of Revenue
-AU$527.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cost of Revenue
AU$815.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cleanspace Holdings Ltd's Cost of Revenue?
Cost of Revenue
-3.7m
AUD
-3.7m
AUD
Based on the financial report for Jun 30, 2023, Cleanspace Holdings Ltd's Cost of Revenue amounts to -3.7m AUD.
What is Cleanspace Holdings Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-9%
-9%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Cleanspace Holdings Ltd have been 21% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
